Amplification-Driven S100A11 Overexpression in Hepatocellular Carcinoma Is Linked to Metabolic Reprogramming, ECM Remodelling, and Immune Evasion: A Pan-Cancer Genomic Study
Stuart Lutimba, Eiman A. Aleem
This study identifies S100A11 overexpression in HCC driven by copy number amplification and links it to metabolic reprogramming, ECM remodelling, and immune evasion.